Article Type
Changed
Mon, 01/14/2019 - 14:00
Display Headline
Foundations Award Funding for Study of Alport Syndrome

The Alport Syndrome Foundation (ASF), Pedersen Family Foundation, and Kidney Foundation of Canada have awarded two research grants for the study of Alport syndrome, a rare genetic kidney disease. The recipients are James Scholey, MD, of the University of Toronto for “Drug Repurposing for the Treatment of Alport Syndrome” and Jeffrey Miner, MD, of Washington University for “WISE Antibody as a Treatment for Alport Syndrome.”

Alport syndrome causes kidney failure, hearing loss, and vision abnormalities. Most affected boys experience kidney failure by the time they reach their early 20s. For affected girls, disease progression often occurs later. There is currently no treatment to prevent kidney failure but early diagnosis is essential as there are medications to delay progression of the disease.

Publications
Legacy Keywords
NORD, rare disease,
Sections

The Alport Syndrome Foundation (ASF), Pedersen Family Foundation, and Kidney Foundation of Canada have awarded two research grants for the study of Alport syndrome, a rare genetic kidney disease. The recipients are James Scholey, MD, of the University of Toronto for “Drug Repurposing for the Treatment of Alport Syndrome” and Jeffrey Miner, MD, of Washington University for “WISE Antibody as a Treatment for Alport Syndrome.”

Alport syndrome causes kidney failure, hearing loss, and vision abnormalities. Most affected boys experience kidney failure by the time they reach their early 20s. For affected girls, disease progression often occurs later. There is currently no treatment to prevent kidney failure but early diagnosis is essential as there are medications to delay progression of the disease.

The Alport Syndrome Foundation (ASF), Pedersen Family Foundation, and Kidney Foundation of Canada have awarded two research grants for the study of Alport syndrome, a rare genetic kidney disease. The recipients are James Scholey, MD, of the University of Toronto for “Drug Repurposing for the Treatment of Alport Syndrome” and Jeffrey Miner, MD, of Washington University for “WISE Antibody as a Treatment for Alport Syndrome.”

Alport syndrome causes kidney failure, hearing loss, and vision abnormalities. Most affected boys experience kidney failure by the time they reach their early 20s. For affected girls, disease progression often occurs later. There is currently no treatment to prevent kidney failure but early diagnosis is essential as there are medications to delay progression of the disease.

Publications
Publications
Article Type
Display Headline
Foundations Award Funding for Study of Alport Syndrome
Display Headline
Foundations Award Funding for Study of Alport Syndrome
Legacy Keywords
NORD, rare disease,
Legacy Keywords
NORD, rare disease,
Sections